Healthwatch: Blood Test for Alzheimer`s & A New Drug for Parkinson`s Disease

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

A cancer drug could help treat degenerative brain disorders, and there could be a new way to detect Alzheimer's disease before symptoms appear.

Researchers from Rowan University are developing a blood test that could detect proteins associated with Alzheimer's Disease. They say it will help doctors diagnose the disease early. Researchers say if Alzheimer's can be detected before symptoms begin, changes can be made to help slow the progression of the disease. Alzheimer's Disease affects more than 5 million Americans.

A higher risk of heart disease could be linked to infections experienced in childhood. Researchers in Indonesia analyzed the health history of more than 300 adults. Those who had prolonged fevers or infectious diseases like Typhoid Fever or Measles as children were three times more likely to suffer premature heart attacks. Cardiovascular disease is the number one killer in the world.

A drug for Leukemia could help reverse the progression of Parkinson's Disease. A small clinical trial at Georgetown University found that the drug, Nilotinib, improved cognition and motor skills in patients with Parkinson's and Lewy Body Dementia, which also affects brain and motor function.

Sponsored by: Mercy Health System


Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.